Angiogenic signalling
Published preclinical work has examined BPC-157 in relation to VEGFR2 signalling and the formation of new microvasculature in injured tissue.
These are results measured on this lot. Full material specification is in Know your compound.
Regenerative Peptide
Studied in preclinical models of tendon, muscle, and gastrointestinal tissue repair.
$30.00 per vial with BOGO
Research use only — not for human or veterinary use, diagnostic or therapeutic.
Know your compound
BPC-157 is a synthetic 15-amino-acid peptide derived from a sequence identified in gastric juice. It is one of the most frequently studied compounds in the regenerative-peptide literature, with the bulk of published work carried out in rodent models.
Reflex supplies BPC-157 as a lyophilized powder for laboratory research use only. Each lot is assayed by an independent U.S. laboratory and ships with its Certificate of Analysis.
Read left to right from the N-terminus. Mass spectrometry checks each lot against this sequence — that result is the “Identity” line on the certificate.
What the molecule is.
How we know the material matches the label.
What arrives, and how it is kept.
What the literature examines
Summaries of what published research has investigated. Preclinical unless stated otherwise — not claims about this product.
Published preclinical work has examined BPC-157 in relation to VEGFR2 signalling and the formation of new microvasculature in injured tissue.
Studies have investigated outcomes in transected tendon and ligament models, measuring fibroblast migration and collagen organisation.
A large portion of the literature examines mucosal integrity in experimental models of gastrointestinal injury.
Certificate of Analysis
Not a brand-wide spec sheet — a lot-specific certificate from an independent laboratory, published before the lot ships and searchable by lot number forever.
Independent U.S. laboratory
Certificate of Analysis · RFX-2606-124
| Test | Specification | Result |
|---|---|---|
| Purity (HPLC) | ≥ 99.0% | 99.4% |
| Identity (LC-MS) | Conforms | Conforms |
| Appearance | White powder | Conforms |
| Net content | Label claim | Conforms |
Class context
| Compound | Origin | Length | Primary study areas |
|---|---|---|---|
| BPC-157 | Gastric juice derived | 15 amino acids | Tendon · GI · angiogenesis |
| TB-500 | Thymosin β4 fragment | 7 amino acids | Cell migration · remodelling |
| KPV | α-MSH fragment | 3 amino acids | Inflammatory models |
Class-level description from published literature. Not a performance comparison.
History
Sequence first described in the gastric-juice protein literature.
Rodent models of tendon and ligament injury published.
Gastrointestinal mucosal-integrity studies expand the literature.
Angiogenesis and growth-factor pathway work continues preclinically.
Questions
No. BPC-157 is not an FDA-approved drug and is not approved for human or veterinary use. It is supplied exclusively as a research material for laboratory use, and it is not intended to diagnose, treat, cure, or prevent any disease.
Yes. Every lot is assayed by an independent U.S. laboratory for purity and identity, and the certificate for the lot you receive is published in our COA library — you can read it before you order.
Purity is quantified by reverse-phase HPLC against a reference standard, and identity is confirmed by mass spectrometry. Both results appear on the lot certificate.
Lyophilized material is typically stored cold and protected from light. Handling and storage are the responsibility of the receiving laboratory; refer to the lot documentation for specifics.
Every second vial is free, sitewide and automatically. Add two vials and you pay for one; add six and you pay for three. Compounds can be mixed, there is no code, and there is no limit.
Orders are processed promptly and shipped with tracking. Free US shipping applies over $100; Priority shipping is $8.95 otherwise.
The guarantee
Have any lot independently re-tested. If the results don't match the purity printed on its published certificate, we refund the order in full — no returns, no argument.
Same research area